Brain cytoplasmic RNA 1 (BCYRN1), also known as BC200, has emerged as a valuable prognostic biomarker in several solid tumors, such as non-small cell lung cancer 20, breast cancer 21, liver cancer 22, and so on. The gene discussed is BCYRN1; the disease is breast carcinoma.